Bone mineral density and hormonal status in men with systemic lupus erythematosus

Lupus

Volumn 5, Issue 6, 1996, Pages 623-626

  Formiga, F ^a   Nolla, J M ^a   Mitjavila, F ^a   Bonnin, R ^a   Navarro, M A ^a   Moga, I ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Bone mineral density; Male; Prolactin; Systemic lupus erythematosus; Testosterone

Indexed keywords

GLUCOCORTICOID; PREDNISONE; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; MALE; PRIORITY JOURNAL; SALIVA; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030445529     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500612     Document Type: Article

References (32)

1. Jackson JA, Kleerekoper MD. Osteoporosis in men: Diagnosis, pathophysiology, and prevention. Medicine 1990; 69: 137-152.
2. Slemenda CW et al. Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992; 117: 286-291.
3. Hannan MT, Felson DT, Anderson JJ. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res 1992; 7: 547-553.
4. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1726-1734.
5. Formiga F et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995; 54: 274-276.
6. Pons F et al. . The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995; 34: 742-746.
7. Dhillon VB et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: A preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 1990; 49: 624-626.
8. Lavalle C et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-272.
9. Folomeev M et al. Prolactin levels in men with SLE and RA. J Rheumatol 1990; 17: 1569-1570.
10. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986; 104: 777-782.
11. Jackson JA, Kleerekoper M, Parfitt AM. Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Intern Med 1986; 105: 543-545.
12. Klibanski A et al. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinolo Metab 1988; 67: 124-130.
13. Sequeira JF et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993; 2: 315-317.
14. Navarro MA, Gòmez JM, Villabona C, Bonnin MR. Salivary testosterone: a good measure to reflect free testosterone. Arch Intern Med 1987; 177: 1189.
15. Tan EM et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
16. Steinbrocker O, Traeger CH, Batterman RE. Therpautic criteria in rheumatoid arthritis. JAMA 1947; 140: 659-667.
17. Isenberg DA, Shoenfeld Y, Schwartz RS. Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum 1984; 27: 132-138.
18. World Health Organisation. Assessment of fracture risk and its application to screening for postraenopausal osteoporosis. WHO Technical Report Series, No. 843. World Health Organisation: Geneva, 1994.
19. Inman RD. Immunologic sex differences and the female preponderance in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 849.
20. Font J et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis 1992; 51: 1050-1052.
21. Pistiner M et al. Lupus erythematosns in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21: 55-64.
22. Ward MM, Studenski S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990; 17: 220-224.
23. Seeman E, Melto MJ III, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75. 977-983.
24. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiology Rev 1985; 7: 178-208.
25. Crilly RG, Francis RM, Nordin BEC. Steroid hormones, ageing and bone. Clin Endocrinol Metab 1981; 10: 115-138.
26. Dykman TR et al. Evaluation of factors associated with glucocorticoid induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985; 28: 361-368.
27. Jackson JA et al. Bone histomorphometry in hypogonadism. Ann Intern Med 1986; 105: 543-545.
28. Babini SM et al. Laxity and rupture of the patellar tendon in systemic lupus erythematosus: association with secondary hyperparathyroidism. J Rheumatol 1988; 15: 1162-1165.
29. Navarro MA et al. PDN-21 in premenopausal women with systemic lupus erythematosus treated with glucocorticoids. J Rheumatol 1995; 22: 2238-2240.
30. Navarro MA et al. Salivary testosterone levels in women with systemic lupus erythematosus. Arthritis Rheum 1992; 35: 557-559.
31. Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989; 110: 526-531.
32. Mateo L et al. Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995; 22: 1455-1460.